- Home
- SANA vs TMS Comparison
SANA vs TMS Comparison
Compare SANA & TMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.63
Company Overview
Basic Information| Metric | SANA | TMS |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.1M | 882.1M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | SANA | TMS |
|---|---|---|
| Price | $3.63 | $8.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.80 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 73.0K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.24 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.61 | $5.04 |
| 52 Week High | $6.55 | $10.10 |
Technical Indicators
Market Signals| Indicator | SANA | TMS |
|---|---|---|
| Relative Strength Index (RSI) | 56.51 | 65.76 |
| Support Level | $3.62 | $6.93 |
| Resistance Level | $3.75 | N/A |
| Average True Range (ATR) | 0.20 | 0.85 |
| MACD | 0.03 | 0.33 |
| Stochastic Oscillator | 72.56 | 78.95 |
Price Performance
Historical Comparison SANA
TMS
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.